Update on genetics and diabetic retinopathy

Blake M. Hampton, Stephen G. Schwartz, Milam A. Brantley, Harry W. Flynn

Research output: Contribution to journalReview article

26 Scopus citations

Abstract

Clinical risk factors for diabetic retinopathy (DR), such as duration of disease and degree of glucose control, do not adequately predict disease progression in individual patients, suggesting the presence of a genetic component. Multiple smaller studies have investigated genotype–phenotype correlations in genes encoding vascular endothelial growth factor, aldose reductase, the receptor for advanced glycation end products, and many others. In general, reported results have been conflicting, due to factors including small sample sizes, variations in study design, differences in clinical end points, and underlying genetic differences between study groups. At this time, there is no confirmed association with any risk allele reported. As we continue to collect data from additional studies, the role of genetics in DR may become more apparent.

Original languageEnglish (US)
Pages (from-to)2175-2193
Number of pages19
JournalClinical Ophthalmology
Volume9
DOIs
StatePublished - Nov 23 2015

Keywords

  • Diabetic retinopathy
  • Genetics
  • Genome-wide association study
  • Single nucleotide polymorphism

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Update on genetics and diabetic retinopathy'. Together they form a unique fingerprint.

  • Cite this